Should Trazodone Be First-Line Therapy for Insomnia? A Clinical Suitability Appraisal. Journal of clinical medicine Pelayo, R., Bertisch, S. M., Morin, C. M., Winkelman, J. W., Zee, P. C., Krystal, A. D. 2023; 12 (8)


Trazodone is one of the most commonly used prescription medications for insomnia; however, some recent clinical guidelines do not recommend its use for treating insomnia. This clinical appraisal critically reviews the scientific literature on trazodone as a first-line treatment for insomnia, with the focus statement "Trazodone should never be used as a first-line medication for insomnia." In addition, field surveys were sent to practicing physicians, psychiatrists, and sleep specialists to assess general support for this statement. Subsequently, a meeting with a seven-member panel of key opinion leaders was held to discuss published evidence in support and against the statement. This paper reports on the evidence review, the panel discussion, and the panel's and healthcare professionals' ratings of the statement's acceptability. While the majority of field survey responders disagreed with the statement, the majority of panel members agreed with the statement based on the limited published evidence supporting trazodone as a first-line agent as they understood the term "first-line agent".

View details for DOI 10.3390/jcm12082933

View details for PubMedID 37109268

View details for PubMedCentralID PMC10146758